Research Products

Genetic Disease Testing

Ashkenazi Testing

A total of 27 mutations in 10 different diseases common to Ashkenazi Jews are detected in four multiplexed assays, developed using the reliable and accurate ARMS technology.

Each assay enables multiple detection of frequent mutations common in Ashkenazi Jews. Each is also separately available as an Elucigene kit to provide complete flexibility for the different needs of mutation screening programs.

Please note: Licenses for the in vitro diagnostic analysis of gene mutations detected by these reagents may be required and are the responsibility of the reagent purchaser.

This product is not approved by the FDA and is not available for sale in the US

DescriptionQuantityCatalogue

Elucigene Ashplex 1
Ashplex 1 detects eight mutations in four of the most common diseases of Ashkenazi Jews and is particularly suited to routine mutation screening for Tay Sachs Disease, Familial Dysautonomia, Canavan Disease and Fanconi Anemia.

To be discontinued
50 test kit
AS008B2

Elucigene Ashplex 2
Ashplex 2 detects seven mutations in four different diseases common to Ashkenazi Jews and can be used for routine mutation detection in Mucolipidosis IV, Niemann-Pick Disease, Glygogen Storage Disease and Blooms Syndrome.

To be discontinued
50 test kit
SS007B2

Elucigene Gaucher
Gaucher Disease is the most common of the ten diseases tested by Elucigene products, with a carrier frequency of 1 in 13 in Ashkenazi Jews. The Elucigene Gaucher kit reliably detects five mutations in the glucocerebrosidase gene that cause Gaucher Disease.

To be discontinued
50 test kit
GD005B2
Cat #ProductKit SizeInstructions for Use
AS008B2 Elucigene Ashplex 1 50 tests EN DA DE EL ES FR IT SV
SS007B2 Elucigene Ashplex 2 50 tests EN DA DE EL ES FR IT PT SV
GD005B2 Elucigene Gaucher 50 tests EN DA DE EL ES FR IT PT SV
Cat #ProductKit SizeMSDS
AS008B2 Elucigene Ashplex 1 50 tests EN DA DE EL ES FR IT PT SV
SS007B2 Elucigene Ashplex 2 50 tests EN DA DE EL ES FR IT PT SV
GD005B2 Elucigene Gaucher 50 tests EN DA DE EL ES FR IT PT SV

All Elucigene gel based kits for Ashkenazi Testing comply with the EC Directive 98/79/EC, carry the CE mark and are manufactured within quality systems accredited to ISO9001:2008 and ISO13485:2003. Full technical support is provided to purchasers of kits to ensure acceptable performance and customer satisfaction.

Elucigene gel based Ashkenazi Testing kits are not approved by the FDA and are not available for sale in the United States.

Please note: Licenses for the in vitro diagnostic analysis of gene mutations detected by these reagents may be required and are the responsibility of the reagent purchaser.

For additional availability in other countries please contact your local sales rep or distributor.

Ashplex 1/Ashplex 2/Gaucher
EN